๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL ยท Real-Time Price ยท USD
1.390
-0.060 (-4.14%)
At close: Nov 20, 2026, 4:00 PM EST
1.319
-0.071 (-5.12%)
After-hours: Nov 20, 2026, 6:22 PM EST

Artelo Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-9.77-11.4-10.11-9.93-10.29-12.13
Net Income
-11.32-12.88-9.83-9.29-10.08-12.11
Earnings Per Share
-0.04-337.93-494.04-508.37-576.57-879.66
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.440.62.3410.4317.5324.11
Total Debt
0.040.680.10.020.060.09
Net Cash (Debt)
4.4-0.082.2310.417.4724.03
Net Cash Growth
474.02%--78.53%-40.45%-27.28%140.97%
Net Cash Per Share
0.02-2.05112.32569.34998.971745.37

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-11.76-8.52-8.35-8.21-8.01-8
Capital Expenditures
------
Free Cash Flow
-11.76-8.52-8.35-8.21-8.01-8
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.